This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization Europe

Speaking Proposals Due 17th May

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Save the Date: 2-4 December 2024
Convention Centre DublinDublin, Ireland

Matthew Vaughan
Technical Project Leader at FUJIFILM Diosynth Biotechnologies
Speaker

Profile

Matthew Vaughan is a Technical Project Leader in the Viral Gene Therapies group at FUJIFILM Diosynth Biotechnologies working on developing various biologics including mammalian and microbial products. He began his career with Fujifilm over 10 years ago, and in his current role, he is responsible for leading the development of a number of client processes from research and development through to both clinical and commercial manufacture. Matthew oversees a number of Fujifilm’s advanced therapies platforms and has a key role in the company’s Advanced Therapies unit in Europe. Matthew has a BSc in Biomedical Sciences from Northumbria University.

Agenda Sessions

  • Overcoming the limitations of ATMP manufacturing through innovation

    12:05
  • Overcoming the limitations of ATMP manufacturing through innovation

    12:05